Title:
SUBSTITUTED NAPHTHYRIDINONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/083210
Kind Code:
A1
Abstract:
Disclosed is a substituted naphthyridinone derivative, which has a structure as shown in formula (I). Further provided are a pharmaceutically acceptable salt, stereoisomer and pharmaceutical composition of the derivative and the medicinal use thereof.
More Like This:
| WO/2003/030898 | MODULATORS OF CCR5 CHEMOKINE RECEPTOR ACTIVITY |
| JP2006515848 | Cylyl ether |
| JPS5291871 | XANTHENE DERIVATIVE AND ANALGESIC DRUGS CONTAINING SAME |
Inventors:
YANG SAI (CN)
HU BIN (CN)
ZHAO ZHIMING (CN)
HU BIN (CN)
ZHAO ZHIMING (CN)
Application Number:
PCT/CN2022/130850
Publication Date:
May 19, 2023
Filing Date:
November 09, 2022
Export Citation:
Assignee:
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN)
YANGTZE RIVER PHARM GROUP CO (CN)
YANGTZE RIVER PHARM GROUP CO (CN)
International Classes:
C07D221/02; A61K31/4353; A61P35/00; C07D401/14; C07D471/04
Domestic Patent References:
| WO2020243376A1 | 2020-12-03 | |||
| WO2018039972A1 | 2018-03-08 |
Foreign References:
| CN113166078A | 2021-07-23 | |||
| CN111936499A | 2020-11-13 | |||
| CN109890822A | 2019-06-14 |
Attorney, Agent or Firm:
ADVANCE CHINA IP LAW OFFICE (CN)
Download PDF: